Leveraging Prior Knowledge in the Development of Human Gene Therapy Products Incorporating Genome Editing
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 2, 2026
June 2, 2026
4ed1473e-e7aa-43b9-89a0-6a6910525833
Related Documents
Safety Assessment of Genome Editing in Human Gene Therapy Products Using Next-Generation Sequencing
Guidance DocumentApril 14, 2026Center for Biologics Evaluation and Research
Innovative Designs for Clinical Trials of Cellular and Gene Therapy Products in Small Populations: Draft Guidance for Industry
Guidance DocumentSeptember 24, 2025Center for Biologics Evaluation and Research
Potency Assurance for Cellular and Gene Therapy Products
Guidance DocumentDecember 27, 2023Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.